Department of Obstetrics,
Gynecology,
and Women's Heath,
Masonic Cancer Center,
and Women’s Heath,
Department of Obstetrics, Gynecology, and Women's Heath,
Department of Obstetrics, Gynecology, and Women’s Heath
Martina Bazzaro has not added Biography.
If you are Martina Bazzaro and would like to personalize this page please email our Author Liaison for assistance.
Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals.
European journal of immunology Jan, 2002 | Pubmed ID: 11754355
Identification of cytotoxic T lymphocyte epitopes of human herpesvirus 8.
Immunology Jul, 2002 | Pubmed ID: 12100728
Cytotoxic T lymphocyte epitope analogues containing cis- or trans-4-aminocyclohexanecarboxylic acid residues.
Bioorganic & medicinal chemistry Sep, 2002 | Pubmed ID: 12110330
Synthesis and activity of N-benzyl pseudopeptides HIV protease inhibitors.
Bioorganic & medicinal chemistry May, 2003 | Pubmed ID: 12735995
Ubiquitin-proteasome system stress sensitizes ovarian cancer to proteasome inhibitor-induced apoptosis.
Cancer research Apr, 2006 | Pubmed ID: 16585202
Myosin II co-chaperone general cell UNC-45 overexpression is associated with ovarian cancer, rapid proliferation, and motility.
The American journal of pathology Nov, 2007 | Pubmed ID: 17872978
Ubiquitin proteasome system stress underlies synergistic killing of ovarian cancer cells by bortezomib and a novel HDAC6 inhibitor.
Clinical cancer research : an official journal of the American Association for Cancer Research Nov, 2008 | Pubmed ID: 19010849
Combination of proteasome and HDAC inhibitors for uterine cervical cancer treatment.
Clinical cancer research : an official journal of the American Association for Cancer Research Jan, 2009 | Pubmed ID: 19147762
α,β-Unsaturated carbonyl system of chalcone-based derivatives is responsible for broad inhibition of proteasomal activity and preferential killing of human papilloma virus (HPV) positive cervical cancer cells.
Journal of medicinal chemistry Jan, 2011 | Pubmed ID: 21186794
Stressing the ubiquitin-proteasome system without 20S proteolytic inhibition selectively kills cervical cancer cells.
PloS one , 2011 | Pubmed ID: 21909374
Establishment, characterization and downstream application of primary ovarian cancer cells derived from solid tumors.
PloS one , 2012 | Pubmed ID: 23226302
Small-molecule RA-9 inhibits proteasome-associated DUBs and ovarian cancer in vitro and in vivo via exacerbating unfolded protein responses.
Clinical cancer research : an official journal of the American Association for Cancer Research Jun, 2014 | Pubmed ID: 24727327
Measurement of deubiquitinating enzyme activity via a suicidal HA-Ub-VS probe.
Methods in molecular biology (Clifton, N.J.) , 2015 | Pubmed ID: 25348307
Simultaneous inhibition of deubiquitinating enzymes (DUBs) and autophagy synergistically kills breast cancer cells.
Oncotarget Feb, 2015 | Pubmed ID: 25784654
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유